Recalled medical system may cause tears, bleeding in heart tissue

The TigerPaw II is a surgical staple used to close tissue in the left atrial appendage of the heart.

The FDA recalled the TigerPaw II by Maquet Medical Systems, because incomplete closure of the it may result in tissue tears and/or bleeding, including a possible tear on the left atrial wall during use of the device.

Maquet Medical Systems received 51 reports of adverse events and one death, according to the FDA.

The TigerPaw II is a surgical staple used to close tissue in the left atrial appendage of the heart.

The affected devices were distributed April 1, 2013 through March 23, 2015. 

 

 

Have You Heard About our Podcasts?
Through the Line podcasts explore innovations and information across the packaging and processing landscape. Join us for the latest insights, trends, and strategies shaping packaging and processing today.
Listen Today
Have You Heard About our Podcasts?
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work